Viewing Viruses Virtually

Viewing Viruses Virtually

By Sphera April 11, 2020

In this edition of the SpheraNOW podcast, James Tehrani, Spark’s editor in chief speaks with Dr. Adrian Mulholland, a chemistry professor at the University of Bristol’s Centre for Computational Chemistry in England, about the VR technology he and his team are developing to research anti-viral medications for COVID-19 and other diseases.

Latest Insights from Sphera
The Best of Spark Delivered to Your Inbox
Sphera is the leading provider of integrated Risk Management software, data and consulting services, with the mission to create a safer, more sustainable and productive world.
Subscribe to Spark
Receive expert content from Sphera about Safety, Sustainability and Productivity.